Recognition of specific antigen through the B-cell receptor (BCR ... and they also have a unique strategic role in the transport of antigen to FDCs in the germinal centre. This wide variety ...
The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient’s malignant tumor cells for the treatment of B-cell lymphomas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback